134 related articles for article (PubMed ID: 34649696)
21. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.
Bouthoorn S; Valstar GB; Gohar A; den Ruijter HM; Reitsma HB; Hoes AW; Rutten FH
Diab Vasc Dis Res; 2018 Nov; 15(6):477-493. PubMed ID: 30037278
[TBL] [Abstract][Full Text] [Related]
22. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community.
Xanthakis V; Enserro DM; Larson MG; Wollert KC; Januzzi JL; Levy D; Aragam J; Benjamin EJ; Cheng S; Wang TJ; Mitchell GF; Vasan RS
JACC Heart Fail; 2016 Oct; 4(10):808-815. PubMed ID: 27395350
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin levels correlate with severity of diabetic cardiomyopathy in early stage of diabetes.
Scuricini A; Andreozzi F; Sgura C; Ministrini S; Bertolotto M; Ramoni D; Liberale L; Camici GG; Mannino GC; Succurro E; Armentaro G; Fiorentino TV; Cassano V; Miceli S; Perticone M; Rubino M; Sesti G; Montecucco F; Sciacqua A; Carbone F
Diabetes Res Clin Pract; 2023 Sep; 203():110885. PubMed ID: 37598938
[TBL] [Abstract][Full Text] [Related]
25. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Rosenstock J; Tang WHW; Zannad F; Lawson F; Perfetti R; Urbinati A
Am Heart J; 2023 Feb; 256():25-36. PubMed ID: 36372245
[TBL] [Abstract][Full Text] [Related]
26. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.
Kapłon-Cieślicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padrón A; Fucili A; Drożdż J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH;
ESC Heart Fail; 2020 Oct; 7(5):2098-2112. PubMed ID: 32618139
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failure.
Coller JM; Gong FF; McGrady M; Shiel L; Liew D; Stewart S; Owen AJ; Krum H; Reid CM; Prior DL; Campbell DJ
ESC Heart Fail; 2022 Feb; 9(1):196-212. PubMed ID: 34850597
[TBL] [Abstract][Full Text] [Related]
28. Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations.
Joyce E; Lala A; Stevens SR; Cooper LB; AbouEzzeddine OF; Groarke JD; Grodin JL; Braunwald E; Anstrom KJ; Redfield MM; Stevenson LW;
JACC Heart Fail; 2016 Dec; 4(12):923-931. PubMed ID: 27908391
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and clinical characteristics of diabetic cardiomyopathy in patients with acute heart failure.
Matsushita K; Harada K; Kohno T; Nakano H; Kitano D; Matsuda J; Takei M; Yoshino H; Yamamoto T; Nagao K; Takayama M
Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1325-1333. PubMed ID: 38218713
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota.
Dandamudi S; Slusser J; Mahoney DW; Redfield MM; Rodeheffer RJ; Chen HH
J Card Fail; 2014 May; 20(5):304-9. PubMed ID: 24576788
[TBL] [Abstract][Full Text] [Related]
31. Echocardiographic screening for non-ischaemic stage B heart failure in the community.
Yang H; Negishi K; Wang Y; Nolan M; Saito M; Marwick TH
Eur J Heart Fail; 2016 Nov; 18(11):1331-1339. PubMed ID: 27813300
[TBL] [Abstract][Full Text] [Related]
32. Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Shah AM; Claggett B; Loehr LR; Chang PP; Matsushita K; Kitzman D; Konety S; Kucharska-Newton A; Sueta CA; Mosley TH; Wright JD; Coresh J; Heiss G; Folsom AR; Solomon SD
Circulation; 2017 Jan; 135(3):224-240. PubMed ID: 27881564
[TBL] [Abstract][Full Text] [Related]
33. Impact of diabetes on heart failure incidence in adults with ischemic heart disease.
Patel N; Chen O; Donahue C; Wang B; Fang Y; Donnino R; Natarajan S
J Diabetes Complications; 2017 Nov; 31(11):1597-1601. PubMed ID: 28947278
[TBL] [Abstract][Full Text] [Related]
34. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
35. Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus.
Wang Y; Yang H; Nolan M; Burgess J; Negishi K; Marwick TH
Cardiovasc Diabetol; 2018 Jan; 17(1):19. PubMed ID: 29368650
[TBL] [Abstract][Full Text] [Related]
36. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
37. Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort.
Campbell DJ; Gong FF; Jelinek MV; Castro JM; Coller JM; McGrady M; Boffa U; Shiel L; Wang BH; Liew D; Wolfe R; Stewart S; Owen AJ; Krum H; Reid CM; Prior DL
Eur J Heart Fail; 2019 Apr; 21(4):449-459. PubMed ID: 30656792
[TBL] [Abstract][Full Text] [Related]
38. Type II diabetes mellitus is a risk factor for heart failure in pre-dialysis patients.
Kuwahara M; Ishigami J; Shikuma S; Akita W; Mori Y; Asai T; Tsukamoto Y; Adachi S; Noda Y; Rai T; Uchida S; Sasaki S
Ther Apher Dial; 2012 Dec; 16(6):541-7. PubMed ID: 23190513
[TBL] [Abstract][Full Text] [Related]
39. Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy.
Frustaci A; Ciccosanti F; Chimenti C; Nardacci R; Corazzari M; Verardo R; Ippolito G; Petrosillo N; Fimia GM; Piacentini M
Int J Cardiol; 2016 Jan; 203():282-9. PubMed ID: 26519687
[TBL] [Abstract][Full Text] [Related]
40. Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study.
Nochioka K; Querejeta Roca G; Claggett B; Biering-Sørensen T; Matsushita K; Hung CL; Solomon SD; Kitzman D; Shah AM
JAMA Cardiol; 2018 Oct; 3(10):939-948. PubMed ID: 30140848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
